Santen Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of SNPHF for the last quarter is 522.83 M USD, and it's 4.23% lower compared to the previous quarter. The net income of Q4 23 is 198.21 k USD.